摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{(6-chloro-naphthalene-2-sulfonyl)-[1-(3-fluoro-2'-methanesulfonylbiphenyl-4-yl)-2-oxo-piperidin-3-yl]amino}acetic acid | 477739-35-8

中文名称
——
中文别名
——
英文名称
{(6-chloro-naphthalene-2-sulfonyl)-[1-(3-fluoro-2'-methanesulfonylbiphenyl-4-yl)-2-oxo-piperidin-3-yl]amino}acetic acid
英文别名
{(6-Chloronaphthalene-2-sulfonyl)-[1-(3-fluoro-2'-methanesulfonylbiphenyl-4-yl)-2-oxo-piperidin-3-yl]amino}-acetic acid;2-[(6-Chloronaphthalen-2-yl)sulfonyl-[1-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-2-oxopiperidin-3-yl]amino]acetic acid
{(6-chloro-naphthalene-2-sulfonyl)-[1-(3-fluoro-2'-methanesulfonylbiphenyl-4-yl)-2-oxo-piperidin-3-yl]amino}acetic acid化学式
CAS
477739-35-8
化学式
C30H26ClFN2O7S2
mdl
——
分子量
645.129
InChiKey
WFYUDPRNHZAOBW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    43
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    146
  • 氢给体数:
    1
  • 氢受体数:
    9

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    {(6-chloro-naphthalene-2-sulfonyl)-[1-(3-fluoro-2'-methanesulfonylbiphenyl-4-yl)-2-oxo-piperidin-3-yl]amino}acetic acidN,N-二乙基-N'-甲基乙二胺4-二甲氨基吡啶 、 TEA 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 2-((6-chloro-N-(1-(3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)-2-oxopiperidin-3-yl)naphthalene)-2-sulfonamido)-N-(2-(diethylamino)ethyl)-N-methylacetamide
    参考文献:
    名称:
    Sulfonamidolactam inhibitors of coagulation factor Xa
    摘要:
    As part of an effort to identify novel backups for previously reported pyrazole-based coagulation Factor Xa inhibitors, the pyrazole 5-carboxamide moiety was replaced by 3-(sulfonylamino)-2-piperidone. This led to the identification of a structurally diverse chemotype that was further optimized to incorporate neutral or weakly basic aryl and heteroaryl P1 groups while maintaining good potency versus Factor Xa. Substitution at the sulfonamide nitrogen provided further improvements in potency and as did introduction of alternate P4 moieties. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.02.054
  • 作为产物:
    描述:
    {(6-chloro-naphthalene-2-sulfonyl)-[1-(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-2-oxo-piperidin-3-yl]-amino}-acetic acid t-butyl ester 在 三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 生成 {(6-chloro-naphthalene-2-sulfonyl)-[1-(3-fluoro-2'-methanesulfonylbiphenyl-4-yl)-2-oxo-piperidin-3-yl]amino}acetic acid
    参考文献:
    名称:
    Sulfonamidolactam inhibitors of coagulation factor Xa
    摘要:
    As part of an effort to identify novel backups for previously reported pyrazole-based coagulation Factor Xa inhibitors, the pyrazole 5-carboxamide moiety was replaced by 3-(sulfonylamino)-2-piperidone. This led to the identification of a structurally diverse chemotype that was further optimized to incorporate neutral or weakly basic aryl and heteroaryl P1 groups while maintaining good potency versus Factor Xa. Substitution at the sulfonamide nitrogen provided further improvements in potency and as did introduction of alternate P4 moieties. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.02.054
点击查看最新优质反应信息

文献信息

  • Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
    申请人:——
    公开号:US20040006062A1
    公开(公告)日:2004-01-08
    The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula I: 1 or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
    本申请描述了Formula I中的磺酰氨基戊内内酰胺及其衍生物,或其药用盐形式,其中环G是单环或双环碳环或杂环。本发明的化合物可用作胰蛋白酶样丝氨酸蛋白酶抑制剂,特别是对凝血因子Xa的抑制剂。
  • Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
    申请人:——
    公开号:US20020183324A1
    公开(公告)日:2002-12-05
    The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of Formula I: 1 or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
    本申请描述了单环或双环碳环和杂环以及其衍生物的化合物I的公式,或其药用可接受的盐形式,这些化合物对于Xa因子的抑制剂具有用处。
  • MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS
    申请人:Bristol-Myers Squibb Pharma Company
    公开号:EP1337251B1
    公开(公告)日:2008-08-20
  • US6710058B2
    申请人:——
    公开号:US6710058B2
    公开(公告)日:2004-03-23
  • US6951872B2
    申请人:——
    公开号:US6951872B2
    公开(公告)日:2005-10-04
查看更多